NUDT15 and leukemia: Using pharmacogenetic approaches, a series of germline variants in NUDT15 that cause thiopurine intolerance through disrupting the enzymatic activity or downregulating the expression level of NUDT15 have been identified, resulting in the accumulation of the toxic thiopurine metabolites in both normal and leukemia cells [24, 25, 26].